About this Journal Submit a Manuscript Table of Contents
Mediators of Inflammation
Volume 2013 (2013), Article ID 381815, 11 pages
http://dx.doi.org/10.1155/2013/381815
Research Article

Alliin, a Garlic (Allium sativum) Compound, Prevents LPS-Induced Inflammation in 3T3-L1 Adipocytes

1Laboratorio de Desarrollo y Regeneración Neural, Instituto de Neurobiología, Departamento de Biología Celular y Molecular, CUCBA, Universidad de Guadalajara, Camino Ing. R. Padilla Sánchez 2100, Las Agujas, 44600 Zapopan, JAL, Mexico
2Departamento de Farmacobiología, CUCEI, Universidad de Guadalajara, Boulevard Marcelino García Barragán, No. 1421, Esquina Calzada Olímpica, 44430 Guadalajara, JAL, Mexico
3Unidad de Farmacología, Departamento de Farmacología y Química Terapéutica, Facultad de Farmacia, Institut de Biomedicina de la UB (IBUB) and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, 08028 Barcelona, Spain

Received 10 September 2013; Revised 3 November 2013; Accepted 9 November 2013

Academic Editor: Giuseppe Valacchi

Copyright © 2013 Saray Quintero-Fabián et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kawada, N. Takahashi, and T. Fushiki, “Biochemical and physiological characteristics of fat cell,” Journal of Nutritional Science and Vitaminology, vol. 47, no. 1, pp. 1–12, 2001. View at Scopus
  2. F. P. de Heredia, S. Gómez-Martínez, and A. Marcos, “Obesity, inflammation and the immune system,” Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 332–338, 2012. View at Publisher · View at Google Scholar
  3. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Trayhurn and I. S. Wood, “Signalling role of adipose tissue: adipokines and inflammation in obesity,” Biochemical Society Transactions, vol. 33, no. 5, pp. 1078–1081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Ferrante Jr., “Obesity-induced inflammation: a metabolic dialogue in the language of inflammation,” Journal of Internal Medicine, vol. 262, no. 4, pp. 408–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Cani, J. Amar, M. A. Iglesias, et al., “Metabolic endotoxemia initiates obesity and insulin resistance,” Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar
  7. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Osborn and J. M. Olefsky, “The cellular and signaling networks linking the immune system and metabolism in disease,” Nature Medicine, vol. 18, no. 3, pp. 363–374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. S. Kim, M. S. Lee, and D. Y. Kown, “Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals,” Annals of the New York Academy of Sciences, vol. 1229, no. 1, pp. 140–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Iciek, I. Kwiecień, and L. Włodek, “Biological properties of garlic and garlic-derived organosulfur compounds,” Environmental and Molecular Mutagenesis, vol. 50, no. 3, pp. 247–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Rose, M. Whiteman, P. K. Moore, and Z. Z. Yi, “Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents,” Natural Product Reports, vol. 22, no. 3, pp. 351–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Gu and Y. Z. Zhu, “Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators,” Expert Review of Clinical Pharmacology, vol. 4, no. 1, pp. 123–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Ariga and T. Seki, “Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review,” BioFactors, vol. 26, no. 2, pp. 93–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ide and B. H. S. Lau, “Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation,” Journal of Nutrition, vol. 131, no. 3, pp. 1020S–1026S, 2001. View at Scopus
  15. V. M. Dirsch, A. K. Kiemer, H. Wagner, and A. M. Vollmar, “Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase,” Atherosclerosis, vol. 139, no. 2, pp. 333–339, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Stoll and E. Seebeck, “Über Alliin, die genuine Muttersubstanz des Knoblauchöls,” Experientia, vol. 3, no. 3, pp. 114–115, 1947. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Sakurai, N. Tsuchimoto, T. Fukumoto, et al., “Decomposition and absorption of S-allyl-L-cysteine sulfoxide in the intestine and culture cells,” in Proceedings of the Annual Meeting of the Japanese Society Society for Bioscience, Biotechnology and Agrochemistry, 2000, abstract 139.
  18. K. T. Augusti and C. G. Sheela, “Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats,” Experientia, vol. 52, no. 2, pp. 115–119, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Colín-González, R. A. Santana, C. A. Silva-Islas, M. E. Chánez-Cárdenas, A. Santamaría, and P. D. Maldonado, “The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection,” Oxidative Medicine and Cellular Longevity, Article ID 907162, 16 pages, 2012. View at Publisher · View at Google Scholar
  20. S. P. Poulos, M. V. Dodson, and G. J. Hausman, “Cell line models for differentiation: preadipocytes and adipocytes,” Experimental Biology and Medicine, vol. 235, no. 10, pp. 1185–1193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Lin, H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer, “The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24255–24263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kopp, C. Buechler, M. Bala, et al., “Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3,” Endocrinology, vol. 151, pp. 1097–1108, 2010. View at Publisher · View at Google Scholar
  23. S. J. Creely, P. G. McTernan, C. M. Kusminski et al., “Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 3, pp. E740–E747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Garcia-Macedo, F. Sanchez-Muñoz, J. C. Almanza-Perez, G. Duran-Reyes, F. Alarcon-Aguilar, and M. Cruz, “Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells,” European Journal of Pharmacology, vol. 587, no. 1–3, pp. 317–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Chakrabarti, B. K. Cole, Y. Wen, S. R. Keller, and J. L. Nadler, “12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes,” Obesity, vol. 17, no. 9, pp. 1657–1663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. An, K. Liu, Y. Zhou, and B. Liu, “Salicylate inhibits macrophage-secreted factors induced adipocyte inflammation and changes of adipokines in 3T3-L1 adipocytes,” Inflammation, vol. 32, no. 5, pp. 296–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Freise, U. Erben, U. Neuman et al., “An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes,” Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1170–1177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Rojas-Mayorquín, N. M. Torres-Ruíz, D. Ortuño-Sahagún, and G. Gudiño-Cabrera, “Microarray analysis of striatal embryonic stem cells induced to differentiate by ensheathing cell conditioned media,” Developmental Dynamics, vol. 237, no. 4, pp. 979–994, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Ortuño-Sahagún, M. C. Rivera-Cervantes, G. Gudiño-Cabrera et al., “Microarray analysis of rat hippocampus exposed to excitotoxicity: reversal Na+/Ca2+ exchanger NCX3 is overexpressed in glial cells,” Hippocampus, vol. 22, no. 2, pp. 128–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Rodríguez-Calvo, L. Serrano, T. Coll et al., “Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2,” Diabetes, vol. 57, no. 8, pp. 2149–2157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Shen, X. Yu, F. Y. Pan, X. Gao, B. Xue, and C. J. Li, “An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism,” Journal of Biological Chemistry, vol. 286, no. 16, pp. 14508–14515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Robinson, J. Prins, and B. Venkatesh, “Clinical review: adiponectin biology and its role in inflammation and critical illness,” Critical Care, vol. 15, pp. 1–9, 2011.
  34. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Ortuño Sahagún, A. L. Márquez-Aguirre, S. Quintero-Fabián, R. I. López-Roa, and A. E. Rojas-Mayorquín, “Modulation of PPAR-γ by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases,” PPAR Research, vol. 2012, Article ID 318613, 17 pages, 2012. View at Publisher · View at Google Scholar
  36. K. M. Ajuwon, W. Banz, and T. A. Winters, “Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes,” Journal of Inflammation, vol. 6, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Zoico, V. Di Francesco, D. Olioso et al., “In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation,” Biogerontology, vol. 11, no. 1, pp. 111–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Frost, G. J. Nystrom, and C. H. Lang, “Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 285, no. 5, pp. R1153–R1164, 2003. View at Scopus
  39. K. M. Ajuwon, S. K. Jacobi, J. L. Kuske, and M. E. Spurlock, “Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-γ in primary pig adipocytes,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 286, no. 3, pp. R547–R553, 2004. View at Scopus
  40. L. Zu, J. He, H. Jiang, C. Xu, S. Pu, and G. Xu, “Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway,” Journal of Biological Chemistry, vol. 284, no. 9, pp. 5915–5926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Song, K. H. Kim, J. M. Yoon, and J. B. Kim, “Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 739–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Chung, K. LaPoint, K. Martinez, A. Kennedy, M. B. Sandberg, and M. K. McIntosh, “Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes,” Endocrinology, vol. 147, no. 11, pp. 5340–5351, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. E. Davis, N. K. Gabler, J. Walker-Daniels, and M. E. Spurlock, “The c-Jun N-terminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes,” Hormone and Metabolic Research, vol. 41, no. 7, pp. 523–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. K. M. Ajuwon and M. E. Spurlock, “Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 5, pp. R1220–R1225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Zoico, U. Garbin, D. Olioso et al., “The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-κB pathway,” International Journal of Molecular Medicine, vol. 24, no. 6, pp. 847–851, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Gómez-Arbeláez, V. Lahera, P. Oubiña, et al., “Garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study,” Mediators of Inflammation, vol. 2013, Article ID 285795, 6 pages, 2013. View at Publisher · View at Google Scholar
  49. A. Yamashita, Y. Soga, Y. Iwamoto et al., “DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin,” International Journal of Obesity, vol. 32, no. 11, pp. 1725–1729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Papatriantafyllou, “Immunometabolism: CD4(+) T cell activation by adipocytes in obesity,” Nature Reviews Immunology, vol. 13, no. 4, article 223, 2013. View at Publisher · View at Google Scholar
  51. J. Palming, B. G. Gabrielsson, E. Jennische et al., “Plasma cells and Fc receptors in human adipose tissue-lipogenic and anti-inflammatory effects of immunoglobulins on adipocytes,” Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 43–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. H. K. Lee, B. H. Lee, S. A. Park, and C. W. Kim, “The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis,” Proteomics, vol. 6, no. 4, pp. 1223–1229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Konno, Y. Wakabayashi, S. Akashi-Takamura et al., “A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expression,” Biochemical and Biophysical Research Communications, vol. 339, no. 4, pp. 1076–1082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. B. E. Hart and R. I. Tapping, “Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B,” Journal of Biological Chemistry, vol. 287, pp. 16550–16562, 2012. View at Publisher · View at Google Scholar
  55. S. N. Rylova, F. Albertioni, G. Flygh, and S. Eriksson, “Activity profiles of deoxynucleoside kinases and 5′-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs,” Biochemical Pharmacology, vol. 69, no. 6, pp. 951–960, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Ma, W. Ding, J. Wang et al., “LOC66273 isoform 2, a novel protein highly expressed in white adipose tissue, induces adipogenesis in 3T3-L1 cells,” Journal of Nutrition, vol. 142, no. 3, pp. 448–455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Gerin, G. T. Bommer, M. E. Lidell, A. Cederberg, S. Enerback, and O. A. McDougald, “On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake,” Journal of Biological Chemistry, vol. 284, no. 16, pp. 10755–10763, 2009. View at Publisher · View at Google Scholar · View at Scopus